EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Distribution of HPV Types in Cervical Cancer in Pakistan: Implications for Screening and Vaccination Programs

Hafsa Aziz iD, Humera Mehmood, Sarosh Arif, Khadija Afzal, Saba Hanif, Muhammad Adnan Saeed, Mohammad Faheem

Journal of Clinical Laboratory Analysis · 2025-01 · 39 (1)

DOI: 10.1002/jcla.25130 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Laboratory Analysis, online erschienen am 05.12.2024. Verfasst von Hafsa Aziz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Nuclear Medicine Oncology and Radiotherapy Institute, Islamabad, Pakistan. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Papillomavirus Infections, Papillomaviridae. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

HPV plays a key role in the development of cervical cancer. This study aims to investigate the prevalence of HPV genotypes in patients with Squamous cell carcinoma (SSC) and Adenocarcinoma (ADC) at NORI cancer Hospital Pakistan, with the aim of improving screening and prevention strategies.

Method

Cervical scrapings were collected from 129 diagnosed cervical cancer patients. HPV typing was performed using a real‐time PCR assay and sequencing.

Result

Among the patients, 73.6% (90/129) were HPV positive. Proportion of HPV positivity was observed within each group. The highest incidence of HPV was observed in the 50–60 years age group (80.9%), followed by the 40‐to‐50‐year group (75.8%). The positivity rate declined in the 60‐to‐70‐year‐old (63.6%) and further in the 70–80 years (62.5%). Eight different HPV subtypes were identified, with HPV 16 being the most prevalent (80.0%), followed by HPV 18 (9.5%), HPV 45 in 2 (2.1%), HPV 31 in 1 (1.1%), HPV 35 in 1 (1.1%), HPV 59 in 1 (1.1%), HPV 66 in 1 (1.1%), and HPV 89 in 1 (1.15). Histologically, 89.2% of the cases were Squamous cell carcinoma (SCC) and 10.8% were Adenocarcinomas. In SCC patients, HPV 16 was found in 80.9% of cases, while in Adenocarcinoma patients, HPV 16 was detected in 66.7% of cases.

Conclusion

The prevalence of high‐risk HPV types, both vaccine and non‐vaccine, targeted in Pakistan highlights the urgent need for widespread screening and vaccination programs. Tailored public health strategies are essential to effectively reduce cervical cancer rates and mortality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsPapillomavirus InfectionsPapillomaviridaeHumansFemalePakistanMiddle AgedAgedAdultAged, 80 and overCarcinoma, Squamous CellEarly Detection of CancerAdenocarcinomaPapillomavirus VaccinesPrevalenceVaccination

Stichwörter der Autor:innen

genotyping of HPV in SCCgenotyping of HPV in adeno carcinomagenotyping of HPV in cervical cancer

Substanzen

Papillomavirus Vaccines

Autor:innen und Institutionen

  • Nuclear Medicine Oncology and Radiotherapy Institute, Islamabad, Pakistan.

ORCID-Profile: Hafsa Aziz

Zitieren

APA

Aziz, H., Mehmood, H., Arif, S., Afzal, K., Hanif, S., Saeed, M. A., & Faheem, M. (2025). Distribution of HPV Types in Cervical Cancer in Pakistan: Implications for Screening and Vaccination Programs. Journal of Clinical Laboratory Analysis, 39(1). https://doi.org/10.1002/jcla.25130

Vancouver

Aziz H, Mehmood H, Arif S, Afzal K, Hanif S, Saeed MA, et al. Distribution of HPV Types in Cervical Cancer in Pakistan: Implications for Screening and Vaccination Programs. Journal of Clinical Laboratory Analysis. 2025;39(1). doi:10.1002/jcla.25130

BibTeX
@article{Aziz2025,
  author = {Aziz, Hafsa and Mehmood, Humera and Arif, Sarosh and Afzal, Khadija and Hanif, Saba and Saeed, Muhammad Adnan and Faheem, Mohammad},
  title = {Distribution of HPV Types in Cervical Cancer in Pakistan: Implications for Screening and Vaccination Programs},
  journal = {Journal of Clinical Laboratory Analysis},
  year = {2025},
  volume = {39},
  number = {1},
  doi = {10.1002/jcla.25130}
}
Kostenlos starten →